Wiener klinische Wochenschrift

, Volume 125, Issue 21–22, pp 674–679 | Cite as

Spectrum of pathogens of in-patient children and youths with community acquired pneumonia: a 3 year survey of a community hospital in Vienna, Austria

  • Herbert Kurz
  • Hubert Göpfrich
  • Klaus Huber
  • Walter Krugluger
  • Friederike Asbott
  • Leila Wabnegger
  • Petra Apfalter
  • Christian Sebesta
original article
First Online:
Received:
Accepted:

Summary

Background

No actual data are available on the epidemiology and morbidity of community acquired pneumonia (CAP) in youths and children in Vienna, Austria.

Objective

The objective was to determine the epidemiology of CAP and morbidity of children hospitalized due to CAP in a tertiary care facility.

Methods

During three winter seasons youths and children hospitalized due to CAP were enrolled. Testing for viral and bacterial pathogens of pneumonia was performed in a routine clinical setting. Blood cultures were performed; respiratory viruses, Mycoplasma pneumoniae and Chlamydia pneumoniae were searched for by an established Real Time polymerase chain reaction (PCR) panel. Clinical signs and indices of inflammation were documented.

Results

Out of 279 children and youths with CAP a causative agent could be detected in 190 (68 %). Viruses and bacteria were diagnosed in 107 (57 %) and 58 patients (30 %), respectively. Co-infection was found in 20 patients (10 %), Mycoplasma pneumoniae or Clamydia pneumoniae in 16 cases (8 %).

In seven patients blood cultures were positive. C-reactive protein (CRP) was significantly higher in children with positive Streptococcus pneumoniae antigen (SPAG) than with viral infection and/or co-infection. Clinical parameters showed no statistically significant differences. C. pneumoniae and M. pneumoniae were only diagnosed in children and youths with 5 years and older.

Conclusions

Testing for pathogens in CAP in clinical routine achieves a high recovery rate. Blood cultures are rarely helpful, but the molecular testing for viruses seemed to be helpful to establish the diagnosis.

Keywords

Community Acquired Pneumonia (CAP)  Children Aetiology  Morbidity Austria 

Das Keimspektrum bei stationär aufgenommenen Kindern und Jugendlichen mit „Community Acquired Pneumonia“ – eine Untersuchung über 3 Jahre in einem Schwerpunktkrankenhaus in Wien, Österreich

Zusammenfassung

Grundlagen

Es gibt keine aktuellen Daten über Epidemiologie und Morbidität von Kindern und Jugendlichen mit „Community Acquired Pneumonia“ (CAP) aus Wien, Österreich.

Ziel

Das Ziel der Studie war, Daten über Epidemiologie und Morbidität von Kindern zu gewinnen, die wegen CAP in einem Tertiärspital stationär aufgenommen waren.

Methodik

Während dreier Wintersaisonen wurden Kinder und Jugendliche in die Studie aufgenommen, die wegen CAP stationär waren. Im Rahmen der klinischen Routine wurden Tests auf Viren und Bakterien gemacht. Blutkulturen wurden abgenommen und mit Hilfe eines PCR Panels wurden respiratorische Viren, Mykoplasmen und Chlamydien gesucht. Symptome und Entzündungsparameter wurden dokumentiert.

Ergebnisse

Von 279 Kindern und Jugendlichen mit CAP wurde bei 190 (68 %) ein auslösendes Agens gefunden. Viren wurden bei 107 Patienten (57 %), Bakterien bei 58 (30 %) nachgewiesen, Koinfektionen bei 20 Patienten (10 %), Mykoplasmen oder Chlamydien in 16 (8 %) Fällen. Bei sieben Patienten war die Blutkultur positiv. C-reaktives Protein (CRP) war bei Kindern mit positivem Pneumokokken-Antigentest signifikant höher als bei jenen mit viralen Infekten und/oder Koinfektion. Klinische Parameter unterschieden sich nicht signifikant. Chlamydia pneumoniae und Mycoplasma pneumoniae wurden nur bei Kindern und Jugendlichen über 5 Jahre diagnostiziert.

Schlussfolgerungen

Die Suche nach Keimen bei CAP kann im klinischen Routinebetrieb eine hohe Ausbeute bringen. Blutkulturen sind kaum hilfreich, aber die molekulare Testung auf Viren lässt häufig eine Diagnose stellen.

Schlüsselwörter

Community Acquired Pneumonia (CAP) Kinder Ätiologie Morbidität Österreich 
This is a preview of subscription content, log in to check access.

Notes

Conflict of interest

All Authors declare that there are no conflicts of interest, there was no funding.

References

  1. 1.
    Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatr. 2004;113:701–7.CrossRefGoogle Scholar
  2. 2.
    Cevey-Macherel M, Galetto-Lacour A, Gervaix A, et al. Etiology of community acquired pneumonia in hospitalized children based on WHO clinical guidelines. Eur J Pediatr. 2009;168:1429–36.PubMedCrossRefGoogle Scholar
  3. 3.
    Fleming DM, Pannell RS, Elliot AJ, et al. Respiratory illness associated with influenza and respiratory syncytial virus infection. Arch Dis Child. 2005;90:741–6.PubMedCrossRefGoogle Scholar
  4. 4.
    Monto AS, Fendrick AM, Sarnes MW. Respiratory illness caused by picornavirus infection: a review of clinical outcomes. Clin Ther. 2001;23:1615–27.PubMedCrossRefGoogle Scholar
  5. 5.
    Boivin G, De Serres G, Côtė S, et al. Human metapneumovirus infections in hospitalized children. Emerg Infect Dis. 2003;9:634–40.PubMedCrossRefGoogle Scholar
  6. 6.
    Mackie PL. The classification of viruses infecting the respiratory tract. Paediatr Respir Rev. 2003;4:84–90.PubMedCrossRefGoogle Scholar
  7. 7.
    Weinberg GA. Parainfluenza viruses: an underappreciated cause of pediatric respiratory morbidity. Pediatr Infect Dis J. 2003;25:447–8.CrossRefGoogle Scholar
  8. 8.
    Mostafaie N, Huber KR, Sebesta C, et al. Diagnosis of infections with human herpes viruses in routine laboratory practice. Clin Chem Lab Med. 2009;47:1141–5.PubMedCrossRefGoogle Scholar
  9. 9.
    British T. BTS Guidelines for the management of community acquired pneumonia in childhood. Thorax. 2002 May;57(Suppl 1):i1–24.Google Scholar
  10. 10.
    World Health Organization Pneumonia Vaccine Trial Investigators Group. Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children. Geneva: World health organization department of vaccines and biologicals, 2001. http://www.who.int/vaccines-documents/DocsPDF01/www616.pdf.
  11. 11.
    Ostapchuk M, Robers DM, Haddy R, et al. Community-acquired pneumonia in infants and children. Am Fam Physician. 2004;70:899–908.PubMedGoogle Scholar
  12. 12.
    British thoracic society standards of care committee. British thoracic society guidelines for the management of community acquired pneumonia in childhood. Thorax. 2002;57 (suppl 1):i1–24.Google Scholar
  13. 13.
    Apfalter P, Loidl M, Nadrchal R, et al. Isolation and continuous growth of Chlamydia pneumoniae from arterectomy specimens. Eur J Clin Microbiol Infect Dis. 2000;19:305–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Kurz H, Göpfrich H, Wabnegger L, et al. Role of Chlamydophila pneumoniae in children hospitalized for community-acquired pneumonia in Vienna, Austria. Pediatr Pulmonol. 2009;44:873–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Nascimento-Carvalho CM, Ribeiro CT, Cardoso MR, et al. The role of respiratory viral infections among children hospitalized for community-acquired pneumonia in a developing country. Pediatr Infect Dis J. 2008;27:939–41.PubMedCrossRefGoogle Scholar
  16. 16.
    Espy MJ, Uhl JR, Mitchel PS, et al. Diagnosis of Herpes Simplex virus infections in the clinical laboratory by LightCycler PCR. J Clinical Mircrobiology. 2000;38:795–9.Google Scholar
  17. 17.
    Charkaluk ML, Kalach N, Mvogo H, et al. Assessment of a rapid urinary antigen detection by an immonocrhormatographic test for diagnosis of pneumococcal infection in children. Diagn Microbiol Infect Dis. 2006;55:89–94.PubMedCrossRefGoogle Scholar
  18. 18.
    Flores JC, Moro MN, Berron S, et al. Usefulness of pneumococcal antigen detection in pleural effusion for the rapid diagnosis of infection by Streptococcus pneumonia. Eur J Pediatr. 2010;169:581–4.CrossRefGoogle Scholar
  19. 19.
    Abe T, Tokuda Y, Ishimatsu S, et al. Usefulness of initial blood cultures in patients admitted with pneumonia from an emergency department in Japan. J Infect Chemother. 2009;15:180–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Kurz H, Göpfrich H. Epidemiology and morbidity of mycoplasma as causative agent for community-acquired pneumonia in hospitalized children in a Community Hospital in Vienna. Wien Med Wochenschr. 2010;161:180–3.PubMedCrossRefGoogle Scholar
  21. 21.
    Don M, Valent F, Korppi M, et al. Differentiation of bacterial and viral community-acquired pneumonia in children. Pediatr Int. 2009;51:91–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Pricipi N, Esposito S. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections. Lancet Infect Dis. 2001;1:334–44.CrossRefGoogle Scholar
  23. 23.
    Block S, Hedrick J, Hammerschlag MR, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. J Pediatr Infect Dis. 1995;14:471–7.CrossRefGoogle Scholar
  24. 24.
    Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53:e25–76.PubMedCrossRefGoogle Scholar
  25. 25.
    Ambroggio L, Taylor JA, Tabb LP, et al. Comparative effectiveness of empiric b-lactam monotherapiy and b-Lactam-Macrolide combination Therapy in Children Hospitalized with Community-Acquired Pneumonia. J Pediatr. 2012;161:1097–103.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2013

Authors and Affiliations

  • Herbert Kurz
    • 1
  • Hubert Göpfrich
    • 1
  • Klaus Huber
    • 2
  • Walter Krugluger
    • 2
  • Friederike Asbott
    • 3
  • Leila Wabnegger
    • 4
  • Petra Apfalter
    • 4
  • Christian Sebesta
    • 5
  1. 1.Department of PaediatricsSMZ Ost Danube Hospital ViennaViennaAustria
  2. 2.Department of Laboratory MedicineDanube Hospital ViennaViennaAustria
  3. 3.Department of PathologyDanube Hospital ViennaViennaAustria
  4. 4.Department of Clinical MicrobiologyInstitute of Hygiene and Medical Microbiology; Medical University ViennaViennaAustria
  5. 5.Department of Internal MedicineDanube Hospital ViennaViennaAustria

Personalised recommendations